# Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism

Study · id `cardio:ct-nct02396758` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02396758](<https://clinicaltrials.gov/study/NCT02396758>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02396758

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.

## Technical summary

Registry record NCT02396758. Randomized; no masking; primary purpose treatment. Start 2015-06-12 (actual); primary completion 2019-04-30 (actual). Results posted on 2021-03-02.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 131 participants (enrolled count; ClinicalTrials.gov record NCT02396758, source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)
- Started: 2015-06-12 (actual) (ClinicalTrials.gov record NCT02396758, source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)
- Primary completion: 2019-04-30 (actual) (ClinicalTrials.gov record NCT02396758, source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)
- Completion: 2020-01-30 (actual) (ClinicalTrials.gov record NCT02396758, source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)
- Results first posted: 2021-03-02 (ClinicalTrials.gov record NCT02396758, source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)
- Countries: United States; United Kingdom (ClinicalTrials.gov record NCT02396758, source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02396758-2021-07-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
- Acronym: OPTALYSE PE
- Condition: Pulmonary Embolism and Thrombosis
- Intervention (Device): Ekosonic® Endovascular Device ultrasonic infusion catheter
- Intervention (Biological): Recombinant tissue plasminogen activator
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY
- Collaborator: EKOS Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial (`cardio:pubmed-30025734`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 97065ac93ca1f0afa9dc3e6b6830877e6192b117058004a55ba7c14071d31d7c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
